Literature DB >> 6247089

Purinergic receptors in the heart.

G Burnstock.   

Abstract

Mesh:

Substances:

Year:  1980        PMID: 6247089

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


× No keyword cloud information.
  9 in total

Review 1.  Cardiac purinergic signalling in health and disease.

Authors:  Geoffrey Burnstock; Amir Pelleg
Journal:  Purinergic Signal       Date:  2014-12-20       Impact factor: 3.765

2.  Cell shock.

Authors:  T V Keaveny
Journal:  Ir J Med Sci       Date:  1988-05       Impact factor: 1.568

3.  Afferent arteriolar vasodilator effect of adenosine predominantly involves adenosine A2B receptor activation.

Authors:  Ming-Guo Feng; L Gabriel Navar
Journal:  Am J Physiol Renal Physiol       Date:  2010-05-12

Review 4.  Role of the adenosine(2A) receptor-epoxyeicosatrienoic acid pathway in the development of salt-sensitive hypertension.

Authors:  Mairéad A Carroll
Journal:  Prostaglandins Other Lipid Mediat       Date:  2011-12-22       Impact factor: 3.072

Review 5.  The therapeutic and diagnostic cardiac electrophysiological uses of adenosine.

Authors:  A D Malcolm; C J Garratt; A J Camm
Journal:  Cardiovasc Drugs Ther       Date:  1993-02       Impact factor: 3.727

6.  Comparative cardiovascular effects of SNP, ATP and phentolamine during norepinephrine-induced hypertension in dogs.

Authors:  K Murata; H Takahashi; K Ikeda
Journal:  J Anesth       Date:  1991-10       Impact factor: 2.078

7.  Appearance of adenosine triphosphate in the perfusate from working frog heart.

Authors:  T B Doyle; T Forrester
Journal:  Pflugers Arch       Date:  1985-09       Impact factor: 3.657

8.  Respiratory stimulant effects of adenosine in man after caffeine and enprofylline.

Authors:  P Smits; J Schouten; T Thien
Journal:  Br J Clin Pharmacol       Date:  1987-12       Impact factor: 4.335

9.  Epoxyeicosatrienoic acids mediate adenosine-induced vasodilation in rat preglomerular microvessels (PGMV) via A2A receptors.

Authors:  M K Cheng; A B Doumad; H Jiang; J R Falck; J C McGiff; M A Carroll
Journal:  Br J Pharmacol       Date:  2004-01-12       Impact factor: 8.739

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.